MMP-3 can distinguish isolated PMR from PMR with GCA: A retrospective study regarding PMR and GCA in Japan

Shoichi Fukui1,2, Takahiro Nunokawa3, Satomi Kobayashi1

  • 1a Department of Rheumatology , Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital , Tokyo , Japan.

Modern Rheumatology
|July 10, 2015
PubMed
Abstract

Insights

Low matrix metalloproteinase-3 (MMP-3) levels predict polymyalgia rheumatica with giant cell arteritis (GCA). Female gender and low creatinine predict relapse in isolated PMR patients.

Area of Science:

  • Rheumatology
  • Clinical Immunology

Background:

  • Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are inflammatory conditions.
  • Distinguishing isolated PMR from PMR with GCA is clinically important.
  • Predicting relapse and corticosteroid discontinuation in isolated PMR aids patient management.

Purpose of the Study:

  • Identify clinical features differentiating isolated PMR from PMR with GCA at diagnosis.
  • Determine predictors of relapse and corticosteroid discontinuation in isolated PMR.

Main Methods:

  • Retrospective study of 115 isolated PMR patients and 29 GCA patients.
  • Comparative analysis between isolated PMR, GCA, and PMR with GCA groups.
  • Logistic regression used to identify relapse and corticosteroid discontinuation predictors in isolated PMR.

Main Results:

  • Matrix metalloproteinase-3 (MMP-3) levels differed significantly between groups: isolated PMR (230.5 ± 201.5 ng/mL), GCA (80.5 ± 47.5 ng/mL), and PMR with GCA (96.8 ± 54.8 ng/mL).
  • Low MMP-3 levels were a positive predictor for PMR with GCA.
  • In isolated PMR, female gender (OR 2.73) and creatinine < 50 μmol/L (OR 2.48) predicted relapse.

Conclusions:

  • Low MMP-3 levels are a strong indicator of PMR with GCA.
  • Female gender and low creatinine are significant predictors of relapse in isolated PMR.
  • These findings aid in differentiating PMR subtypes and predicting disease course.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
451
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.1K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
326